The estimated Net Worth of Harish Manwani is at least 1.03 百万$ dollars as of 3 May 2022. Mr. Manwani owns over 2,223 units of Gilead Sciences stock worth over 637,564$ and over the last 13 years he sold GILD stock worth over 0$. In addition, he makes 394,977$ as Independent Director at Gilead Sciences.
Harish has made over 9 trades of the Gilead Sciences stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 2,223 units of GILD stock worth 179,930$ on 3 May 2022.
The largest trade he's ever made was exercising 5,099 units of Gilead Sciences stock on 8 March 2019 worth over 412,713$. On average, Harish trades about 377 units every 26 days since 2011. As of 3 May 2022 he still owns at least 7,877 units of Gilead Sciences stock.
You can see the complete history of Mr. Manwani stock trades at the bottom of the page.
Harish M. Manwani serves as Independent Director of the Company. Mr. Manwani is a Senior Operating Partner at The Blackstone Group L.P., a leading global alternative asset manager, which he joined in 2015. He previously was Chief Operating Officer of the Unilever Group from 2011 until his retirement in 2014. Mr. Manwani joined Unilever in 1976 as a management trainee in India and held senior management roles around the world, including North America, Latin America, Asia, Africa and Central and Eastern Europe. Mr. Manwani is an honors graduate from Bombay University. He holds a master’s degree in Management Studies, and he attended the Advanced Management Program at Harvard Business School. Mr. Manwani is the Chairman of Board of the Indian School of Business, and also serves on the board or directors of Whirlpool Corporation, Qualcomm Incorporated, Nielsen Holdings plc., EDBI Pte Ltd. and Tata Sons Private Limited. He previously served as the non-executive Chairman of Hindustan Unilever Limited from 2005 to 2018, and as a member of the board of directors of The Economic Development Board of Singapore from 2013 to 2019 and Pearson plc from 2013 to 2018.
As the Independent Director of Gilead Sciences, the total compensation of Harish Manwani at Gilead Sciences is 394,977$. There are 14 executives at Gilead Sciences getting paid more, with Daniel O'Day having the highest compensation of 29,107,900$.
Harish Manwani is 66, he's been the Independent Director of Gilead Sciences since 2018. There are 5 older and 20 younger executives at Gilead Sciences. The oldest executive at Gilead Sciences, Inc. is Richard Whitley, 74, who is the Independent Director.
Harish's mailing address filed with the SEC is 333 LAKESIDE DRIVE, , FOSTER CITY, CA, 94404.
Over the last 22 years, insiders at Gilead Sciences have traded over 221,090,692$ worth of Gilead Sciences stock and bought 30,121 units worth 1,879,767$ . The most active insiders traders include John C Martin、Norbert W Bischofberger、John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of 3,341,365$. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth 51,721$.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: